4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-19-000428
Director sold 8,347 shares at $219.33 ($1,830,731)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Nusse Roeland · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-11-25 | Exercise or conversion : show line 1 in the form | +10,000 | $60.46 | $604,600 | 15,721 | D |
| 2019-11-25 | Exercise or conversion : show line 2 in the form | +5,000 | $61.46 | $307,300 | 20,721 | D |
| 2019-11-25 | Sale : show line 3 in the form | −8,347 | $219.33 | $1,830,731 | 12,374 | D |
| Open-market sales · 8,347 sh · avg $219.33 · $1,830,731 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-11-25 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −10,000 | 0 | D |
| 2019-11-25 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −5,000 | 0 | D |
Loading xslF345X03/edgar.xml…